Phase II study of cis-diammine(glycolato)platinum, 254-S, in patients with advanced germ-cell testicular cancer, prostatic cancer, and transitional-cell carcinoma of the urinary tract. 254-S Urological Cancer Study Group.

Source:http://linkedlifedata.com/resource/pubmed/id/1334448

Download in:

View as

General Info

PMID
1334448